Holly Miller

Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report

Outcomes following matched sibling donor transplantation for severe combined immunodeficiency: a report from the PIDTC

Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment

Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD

Severe eczema in Wiskott–Aldrich syndrome‐related disorder successfully treated with dupilumab

Efficacy of Azacitidine and Prophylactic Donor Lymphocyte Infusion after HSCT in Pediatric Patients with Acute Myelogenous Leukemia: A Retrospective Pre-Post Study

Lentiviral Gene Therapy for Artemis-Deficient SCID

The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions

Effects of an exercise program during pediatric stem cell transplantation: A randomized controlled trial

High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia

Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report

CRISPR-based gene editing enables <i>FOXP3</i> gene repair in IPEX patient cells

Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey

Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers

Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT

A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study